F Alexander-Sefre

Summary

Affiliation: Queen Mary
Country: UK

Publications

  1. ncbi Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer
    F Alexander-Sefre
    ICRF Translational Oncology Laboratory, St Bartholomew s and the Royal London Medical and Dental School, London EC1 M 6BQ, UK
    Gynecol Oncol 92:653-9. 2004
  2. ncbi Assessment of the depth of myometrial invasion in stage I endometrioid endometrial cancer using pancytokeratin immunohistochemistry
    F Alexander-Sefre
    ICRF Translational Oncology Laboratory, St Bartholomew s and the Royal London Medical and Dental School, Charterhouse Square, London, UK
    Int J Gynecol Cancer 14:665-72. 2004
  3. ncbi Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry
    F Alexander-Sefre
    Gynaecological Cancer Research Centre, St Bartholomew s and The London School of Medicine, London EC1M 6BQ, UK
    J Clin Pathol 56:786-8. 2003
  4. ncbi Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?
    A G Rockall
    Department of Radiology, Dominion House, St Bartholomew s Hospital, West Smithfield, London EC1A 7ED, UK
    Gynecol Oncol 101:244-9. 2006
  5. ncbi Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence
    F Alexander-Sefre
    The North Hampshire Hospital, Basingstoke, UK
    Colorectal Dis 7:382-6. 2005
  6. ncbi Gynaecological malignancy in pregnancy
    F Alexander-Sefre
    J Obstet Gynaecol 25:327-9. 2005
  7. ncbi Evaluation of endometrial carcinoma on magnetic resonance imaging
    A G Rockall
    Department of Radiology, St Bartholomew s Hospital, West Smithfield, 59 Bartholomew Close, West Smithfield, London, United Kingdom
    Int J Gynecol Cancer 17:188-96. 2007

Detail Information

Publications7

  1. ncbi Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer
    F Alexander-Sefre
    ICRF Translational Oncology Laboratory, St Bartholomew s and the Royal London Medical and Dental School, London EC1 M 6BQ, UK
    Gynecol Oncol 92:653-9. 2004
    ..Dual immunostaining for epithelial and endothelial cell markers cell markers has been shown to increase detection rate of LVSI significantly...
  2. ncbi Assessment of the depth of myometrial invasion in stage I endometrioid endometrial cancer using pancytokeratin immunohistochemistry
    F Alexander-Sefre
    ICRF Translational Oncology Laboratory, St Bartholomew s and the Royal London Medical and Dental School, Charterhouse Square, London, UK
    Int J Gynecol Cancer 14:665-72. 2004
    ..Tumor cells can evade detection by light microscopy if they are vastly outnumbered by myometrial cells. Immunohistochemical (IHC) techniques against pancytokeratins (PCKs) have a great potential in the detection of such isolated cells...
  3. ncbi Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry
    F Alexander-Sefre
    Gynaecological Cancer Research Centre, St Bartholomew s and The London School of Medicine, London EC1M 6BQ, UK
    J Clin Pathol 56:786-8. 2003
    ..Lymphovascular space invasion (LVSI) is an important step in the complex process of tumour metastasis. Various methods have been used in the past to improve the histological detection of LVSI...
  4. ncbi Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?
    A G Rockall
    Department of Radiology, Dominion House, St Bartholomew s Hospital, West Smithfield, London EC1A 7ED, UK
    Gynecol Oncol 101:244-9. 2006
    ..Our objective was to evaluate whether MRI could be used to select patients who did not require invasive staging of the bladder or rectum...
  5. ncbi Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence
    F Alexander-Sefre
    The North Hampshire Hospital, Basingstoke, UK
    Colorectal Dis 7:382-6. 2005
    ..CONCLUSION: PMP patients with elevated CEA, or more than one abnormal serum tumour maker, are at risk of developing recurrent disease...
  6. ncbi Gynaecological malignancy in pregnancy
    F Alexander-Sefre
    J Obstet Gynaecol 25:327-9. 2005
  7. ncbi Evaluation of endometrial carcinoma on magnetic resonance imaging
    A G Rockall
    Department of Radiology, St Bartholomew s Hospital, West Smithfield, 59 Bartholomew Close, West Smithfield, London, United Kingdom
    Int J Gynecol Cancer 17:188-96. 2007
    ..Dynamic enhancement did not improve diagnostic performance. MRI may allow accurate categorization of cases into low- or high-risk groups ensuring suitable extent of surgery and adjuvant therapy...